INTRODUCTION

SCREENING OF PERNICIOUS ANEMIA, PRIMARY BILIARY CIRRHOSIS (PBC) AND TYPE 2 AUTO-IMMUNE HEPATITIS

Simultaneous detection of anti-PCA and anti-IF, anti-ribosomal P, anti-mitochondria M2, anti-LKM1 and anti-LC1 antibodies

The FIDIS™ CYTO-PANEL detects the presence of clinically relevant circulating auto antibodies which may be useful as an aid in the diagnosis of Pernicious Anemia (PA), Primary Biliary Cirrhosis (PBC) and type 2 Auto-Immune Hepatitis.

PRODUCT ADVANTAGES

Eficient and flexible

• Up to 92 patients and 184 results in 90 minutes
• 2h for the confirmation of the PA
• High throughput testing for rapid diagnosis
• Improved turn around time of results

Automation

• Save laboratories from manual assays
• Easily adapted to automation using CARIS™
• Enhanced security using Barcode Reader for reagents and samples
• Ability of multi-batch with all range of FIDIS™ reagents: FIDIS™ Vasculitis, Celiac A, Celiac G, Thyro, Rheuma, Cyto-Panel

Fast and simple interpretations

• Using FIDIS™ analyser and MLX-BOOSTER software:
  • results automatically calculated
  • efficient and friendly
  • intuitive interface
• Results given in
  • Arbitrary Unit/mL (AU/mL)
  

TESTPRINCIPLE

FIDIS™ CYTO-PANEL is intended for the semi-quantitative detection of antibodies based on microsphere immunoassay using Luminex® technology.

ANTIGENS

* Internal Standard Bead confirms the presence of sera and conjugate.

QUALITY

• FIDIS™ CYTO-PANEL is the first test based on Luminex® Technology
• FIDIS™ CYTO-PANEL is designed for the simultaneous detection of antibodies directed against ATPase H+/K+ of the gastric parietal cells (PCA) and the intrinsic factor (IF), LKM1, LC1, Mitochondria M2, Ribosomal P
• Simultaneous multiple analysis save laboratories time and money

HANDELSFORM